MICHAELA MANIAS: Open Payments
NPI 1154178150 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,374 in 83 payments from 38 companies in 2025. Trend: 2023 $0 · 2024 $512 · 2025 $2,374
Food & beverage: $2,258Education: $116
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $407 |
| Regeneron Healthcare Solutions, Inc. | 8 | $197 |
| Stryker Corporation | 1 | $163 |
| Janssen Biotech, Inc. | 3 | $146 |
| Merck Sharp & Dohme LLC | 7 | $140 |
| Eisai Inc. | 6 | $111 |
| SEAGEN INC. | 1 | $100 |
| Daiichi Sankyo Inc. | 4 | $93 |
| GENZYME CORPORATION | 3 | $86 |
| PFIZER INC. | 4 | $72 |
Products named: DATROWAY, LIBTAYO, OPTABLATE, IMFINZI, KEYTRUDA, Lenvima, RYBREVANT, ENHERTU.
Industry payments across GA — which companies pay providers there.
